Search research articles
Contact Us
Filters
Showing results (261-270 of 279) with videos related to
Page
of 28
Sort By:
Alimentary Pharmacology & Therapeutics
|
January 29, 2000
Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices
D J Cullen, J M Seager, S Holmes, et al.
BMJ (Clinical Research Ed.)
|
July 4, 1992
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis
A B Hawthorne, R F Logan, C J Hawkey, et al.
Scandinavian Journal of Gastroenterology
|
October 9, 2003
An irritable bowel syndrome-specific symptom questionnaire: development and validation
I K Wiklund, S Fullerton, C J Hawkey, et al.
Gut
|
July 1, 1992
Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial
A B Hawthorne, T K Daneshmend, C J Hawkey, et al.
Gut
|
August 13, 2003
Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer
L Jackson, W Wahli, L Michalik, et al.
Liver
|
October 1, 1983
A monoclonal antibody reactive with human hepatocytes
C H Holmes, C J Hawkey, B Gunn, et al.
Lancet (London, England)
|
October 6, 1998
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention
C J Hawkey, Z Tulassay, L Szczepanski, et al.
Alimentary Pharmacology & Therapeutics
|
January 29, 2000
Ibuprofen versus other non-steroidal anti-inflammatory drugs: use in general practice and patient perception
J M Seager, D J Cullen, G Pearson, et al.
Gastroenterology
|
March 7, 2001
Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production
N J Wight, K Gottesdiener, N M Garlick, et al.
The New England Journal of Medicine
|
May 30, 1996
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs
A S Taha, N Hudson, C J Hawkey, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 279) with videos related to
Sort By:
Page
of 28
Alimentary Pharmacology & Therapeutics
|
January 29, 2000
Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices
D J Cullen, J M Seager, S Holmes, et al.
BMJ (Clinical Research Ed.)
|
July 4, 1992
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis
A B Hawthorne, R F Logan, C J Hawkey, et al.
Scandinavian Journal of Gastroenterology
|
October 9, 2003
An irritable bowel syndrome-specific symptom questionnaire: development and validation
I K Wiklund, S Fullerton, C J Hawkey, et al.
Gut
|
July 1, 1992
Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial
A B Hawthorne, T K Daneshmend, C J Hawkey, et al.
Gut
|
August 13, 2003
Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer
L Jackson, W Wahli, L Michalik, et al.
Liver
|
October 1, 1983
A monoclonal antibody reactive with human hepatocytes
C H Holmes, C J Hawkey, B Gunn, et al.
Lancet (London, England)
|
October 6, 1998
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention
C J Hawkey, Z Tulassay, L Szczepanski, et al.
Alimentary Pharmacology & Therapeutics
|
January 29, 2000
Ibuprofen versus other non-steroidal anti-inflammatory drugs: use in general practice and patient perception
J M Seager, D J Cullen, G Pearson, et al.
Gastroenterology
|
March 7, 2001
Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production
N J Wight, K Gottesdiener, N M Garlick, et al.
The New England Journal of Medicine
|
May 30, 1996
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs
A S Taha, N Hudson, C J Hawkey, et al.
Page
of 28